MAP855

Biorbyt

MAP855

10

Research Use Only

C28H23CLF2N6O3

564.97

MAP855 is a novel highly potent and selective MEK1/2 kinase inhibitor with equipotent inhibition of WT and mutant MEK1/2, whose drug-like properties allow further investigation in the mutant MEK setting upon BRAF/MEK therapy.

C(=O)(N1CC[C@H](N2C3C4C(N=CC=3N=C2C)=CC(F)=C(C2=CC=C(OC3=NC=CC=N3)C=C2Cl)C=4)[C@@H](F)C1)CO

12352200